Wesley D Kufel
Overview
Explore the profile of Wesley D Kufel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kufel W, Steele J, Mahapatra R, Brodey M, Wang D, Paolino K, et al.
Infect Control Hosp Epidemiol
. 2024 Jan;
45(5):609-617.
PMID: 38268340
Objective: Evaluation of adult antibiotic order sets (AOSs) on antibiotic stewardship metrics has been limited. The primary outcome was to evaluate the standardized antimicrobial administration ratio (SAAR). Secondary outcomes included...
12.
Li J, Cosler L, Harausz E, Myers C, Kufel W
Pharmacotherapy
. 2023 Nov;
44(2):197-206.
PMID: 37986168
Urinary tract infections (UTIs) commonly affect many patient populations. Recurrent UTIs (rUTIs) can be particularly problematic and lead to potential hospitalizations, multiple antibiotic courses, and have a potential negative impact...
13.
Hitchcock A, Kufel W, Seabury R, Steele J
J Pharm Pract
. 2023 Nov;
37(5):1073-1081.
PMID: 37931904
Cefazolin is guideline recommended for perioperative prophylaxis in orthopedic surgery. Despite its unique R1 side chain, cefazolin is often avoided in patients with beta-lactam allergy with concern for cross reactivity....
14.
Collins C, Dumkow L, Kufel W, Nguyen C, Wagner J
Am J Health Syst Pharm
. 2023 Oct;
80(21):1577-1581.
PMID: 37879095
No abstract available.
15.
Hitchcock A, Kufel W, Dwyer K, Sidman E
Int J Antimicrob Agents
. 2023 Oct;
63(1):107009.
PMID: 37844807
Patients living with multidrug-resistant (MDR) HIV have limited antiretroviral regimen options that provide durable viral suppression. Lenacapavir is a novel first-in-class inhibitor of HIV-1 capsid function with efficacy at various...
16.
Kufel W, Zagoria Z, Blaine B, Steele J, Mahapatra R, Paolino K, et al.
Ann Pharmacother
. 2023 Aug;
58(4):360-365.
PMID: 37542415
Background: The preferred antibiotic salvage regimen for persistent methicillin-susceptible bacteremia (MSSAB) is unclear. Ertapenem with cefazolin or an antistaphylococcal penicillin has been primarily described, but identifying alternative carbapenem-sparing options may...
17.
Kufel W, Parsels K, Blaine B, Steele J, Seabury R, Asiago-Reddy E
Int J Antimicrob Agents
. 2023 May;
62(1):106843.
PMID: 37160238
Background: The risk of linezolid-associated serotonin toxicity remains unclear. This study sought to evaluate the incidence of serotonin toxicity among hospitalized patients who received linezolid with or without concurrent serotonergic...
18.
Kufel W, Hitchcock A, Delbalso A, Paolino K
J Antimicrob Chemother
. 2023 Feb;
78(4):1127-1128.
PMID: 36790902
No abstract available.
19.
Field A, Seabury R, Kufel W, Darko W, Miller C, Mastro K, et al.
Surg Infect (Larchmt)
. 2023 Feb;
24(2):177-182.
PMID: 36723503
Compliance with guideline recommendations for surgical antibiotic prophylaxis (SAP) in colorectal surgery, particularly redosing, has been suboptimal at many institutions including ours. This study aimed to evaluate if single-dose antibiotic...
20.
Kufel W, Parsels K, Blaine B, Steele J, Mahapatra R, Paolino K, et al.
Pharmacotherapy
. 2022 Nov;
43(1):15-23.
PMID: 36371648
Study Objective: The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus ceftaroline for persistent...